Oncofusion

start / graph / gene-khdrbs1

Genemoderate confidence 3 of 5: One strong study, or several smaller consistent ones.Q6-interactome-rna-layer

KHDRBS1 (Sam68) — an RNA-binding protein that holds the MLL-AF4 message DOWN, a class no dropout screen can find

also called Sam68 · SAM68 · p62 · p68 · GSG1 · KH domain containing, RNA binding, signal transduction associated 1

Sam68 is a protein that grips the messenger RNA of the MLL-AF4 fusion and makes the ribosome stall, so less fusion protein gets made. It is a brake on the cancer gene rather than a helper, which is why every screen that looks for genes cancer cells need has missed it.

The same thing, for a scientist

KHDRBS1/Sam68 is a KH-domain STAR-family RNA-binding protein. In the only study that places it on this fusion, MLL-AF4 translation is inhibited by ribosomal stalling at regulatory sites containing AU-rich sequences recognised by KHDRBS-family proteins; synonymous mutations that disrupt KHDRBS association restore proper MLL-AF4 translation and produce leukaemic transformation, and the synonymous mutant induces leukaemia in vivo [E1]. The direction matters: KHDRBS1 is a **negative** regulator of the oncoprotein's dose, so its loss should be permissive rather than lethal. DepMap agrees by being flat and slightly positive - Chronos mean -0.127, 4.2% of 1,208 lines depleted, and +0.087 lymphoid / +0.059 myeloid in the KMT2A-rearranged index arm, at the 91.5th percentile of a random-gene null [E2]. A CRISPR dropout screen cannot enumerate a brake, and this entry exists as the worked example of that blind spot.

Go deeper
Why this entry is the beat's most important one

The Q5 interactome beat holds over 100 entries built from protein-complex membership, and gene-igf2bp3 diagnosed the resulting blind spot as 'enumeration from protein-complex membership finds proteins that bind the fusion, and misses a post-transcriptional regulator that never touches it'.

KHDRBS1 is a second, deeper version of the same blind spot, and it defeats both of this project's instruments at once:

  • It never touches the fusion protein, so complex-membership enumeration cannot reach it.
  • It restrains the fusion, so a dependency screen - which scores loss of fitness on knockout - cannot reach it either, in either direction. Its DepMap row looks like a gene that does not matter 2, and that is exactly what the published mechanism predicts it should look like 1.

Every beat in this graph that has concluded 'no dependency, therefore dispensable' has been using an instrument that is by construction blind to the entire class of negative regulators. This is the first entry to say so with a worked example in the index disease.

What the mechanism is, and what it implies about modelling this disease

The Yokoyama paper's framing is worth reading literally. It opens by noting that establishing a murine MLL-AF4 disease model by retroviral transduction has been difficult, and it resolves that difficulty post-transcriptionally: the construct is not translated efficiently because KHDRBS proteins bind AU-rich regulatory sites and stall the ribosome. Remove those sites synonymously - no change to the protein sequence at all - and the same construct transforms and causes leukaemia in vivo 1.

Two consequences the graph should carry.

First, a negative modelling result is re-interpretable. Years of failure to model MLL-AF4 in mouse were read as evidence about the fusion's transforming capacity or its cell-of-origin requirements. At least part of it was a translational ceiling on the construct. Any experiment in this graph that concluded something from a low-penetrance MLL-AF4 model inherits that ambiguity.

Second, fusion dose is a regulated variable. This graph treats KMT2A::AFF1 as present or absent. If KHDRBS occupancy sets how much fusion protein a cell makes from a given transcript, then dose is set post-transcriptionally and could differ between cells carrying the identical translocation.

The leukaemia literature on Sam68 itself, counted

Sam68 has a leukaemia literature, and it is thin and elsewhere. Title-checked PubMed counts run this session:

queryrecordsafter title check
SAM68 AND leukemia132 direct functional studies, both adult T-ALL
(MLL OR KMT2A) AND (KHDRBS1 OR Sam68 OR p68 OR p62 OR GSG1)5the alias set is badly inflated: p62 and p68 are used for unrelated proteins across several fields
KHDRBS AND leukemia1the family-name term returns only 1 itself

The direct functional work is in adult T-ALL, where Sam68 silencing reduces proliferation and promotes apoptosis through AKT/mTOR 3 - an ordinary pro-proliferative role, opposite in sign to the MLL-AF4 result. There is no published work on Sam68 in KMT2A-rearranged B-lymphoid leukaemia.

Note which way the alias rule cut here. The family term KHDRBS was reachable and returned exactly the paper that matters, unlike the NSL case this project logged in cycle 45 where no subunit or family query reached the decisive paper. The short aliases p62 and p68 did the opposite and inflated the count with unrelated fields, which is why the number above is given title-checked rather than raw.

Facts and figures
uniprotQ07666
length AA443
gene symbolKHDRBS1
uniprot resolutiongene_exact:KHDRBS1 AND organism_id:9606 AND reviewed:true; one hit; primary gene name read back as KHDRBS1; length 443 aa checked
rna functionKH-domain STAR-family RNA-binding protein; binds AU-rich regulatory sites and, on the MLL-AF4 message, causes ribosomal stalling that inhibits translation
subnuclear localizationSAM68 NUCLEAR BODIES (SNBs) - A NAMED, DISTINCT SUBNUCLEAR ORGANELLE, AND THEY ARE PREDOMINANTLY FOUND IN TRANSFORMED CELLS. Chen and colleagues showed that Sam68 concentrates into novel nuclear structures predominantly present in TRANSFORMED cells; that SNBs are DISTINCT FROM COILED BODIES, GEMS AND PROMYELOCYTIC NUCLEAR BODIES; that electron microscopy shows them to be discrete structures enriched in phosphorus and nitrogen, indicating nucleic acids; that GFP-Sam68 reproduces the endogenous pattern in HeLa - diffusely nuclear with TWO TO FIVE SNBs; that SLM-1 and SLM-2 co-localise in them; and that GSG-domain missense mutations produce six separable cellular patterns including exclusive SNB localisation and association with MICROTUBULES [E_q93_khdrbs1_loc2]. A 2009 proteomic follow-up describes SNBs as subnuclear organelles containing splicing regulators, signalling components and nucleic acids, and identifies hnRNP L as a specific component that hnRNP LL does not share [E_q93_khdrbs1_loc3]. CONSTITUTIVE VERSUS INDUCED, WHICH THIS BEAT ASKS FOR: the DIFFUSE nucleoplasmic pool is constitutive; the SNBs are TRANSFORMATION-ASSOCIATED, few in number (two to five per nucleus), and the 2009 work explicitly used a cell line with a LOW FREQUENCY of SNBs, showing the Sam68-hnRNP L interaction also occurs outside them. So SNBs are a facultative body rather than the protein's address.
localization shown for fusionNO - nobody has localised Sam68 in any KMT2A fusion, in any lineage, and the gap is sharper than usual because this entry's own mechanism is compartment-dependent. The gene clause over KHDRBS1, Sam68 and SAM68 returns 503 records, against a nine-term KMT2A/MLL fusion clause returns 2 (PMIDs 17891136 and 16330219, neither a localisation measurement), and against a localisation clause AND the fusion clause returns ZERO [E_q93_khdrbs1_loc6]. The unasked question: MLL-AF4 mRNA is stalled on cytoplasmic ribosomes by a protein that is predominantly nuclear, so does a KMT2A-rearranged blast have an unusual Sam68 partition, or unusual SNB content, and does the synonymous-mutation escape this entry already records correlate with either?
essentiality
{
  "depmap_common_essential": false,
  "chronos_mean": -0.127,
  "pct_lines_depleted": 4.2,
  "n_lines": 1208,
  "kmt2a_r_lymphoid_diff": 0.087,
  "kmt2a_r_myeloid_diff": 0.059,
  "null_percentile": 91.48
}
pubmed counts title checked
{
  "SAM68 AND leukemia": "13 raw, 2 direct functional (both adult T-ALL)",
  "KHDRBS AND leukemia": 1,
  "(MLL OR KMT2A) AND KHDRBS1/Sam68/p68/p62/GSG1": "5 raw, alias-inflated by p62 and p68"
}
depmap kmt2a selectivity
{
  "chronos_mean_kmt2a_rearranged": -0.0909,
  "chronos_mean_other_leukaemia": -0.1601,
  "difference": 0.0692,
  "pan_essentiality_all_lines": -0.1273,
  "selectivity_rank": 15942,
  "rank_denominator": 17728,
  "provenance": "Joined 2026-09-21 from analyses/depmap-kmt2a-selective-scan-full (generated 2026-09-19T10:12:06Z), the project's own genome-wide scan over 11 KMT2A-rearranged and 43 other leukaemia DepMap lines. NOT re-fetched and NOT independent of that scan: every caveat it carries applies here, including that the KMT2A-rearranged arm is a small number of lines drawn from nine individuals, that the rank denominator is 17,728 genes, and that a difference is not a dependency. Added because only 26 of 308 gene entries carried this number, which made any KMT2A-selectivity question answerable for 8% of the corpus.",
  "how_to_read": "A negative difference means MORE required in KMT2A-rearranged lines than in other leukaemia lines. A rank near 17,728 is ANTI-selective. Neither is evidence of a fusion-driven dependency on its own: check pan_essentiality_all_lines before calling anything selective, and note that a paralogue-redundant gene can score near zero for reasons that have nothing to do with this disease - see ana-the-paralogue-redundancy-excuse-is-not-tested-and-my-proxy-decided-the-answer."
}
localization
{
  "CONSTITUTIVE": "PREDOMINANTLY NUCLEAR, PARTLY CYTOPLASMIC. UniProt Q07666 (fetched live 2026-09-21) carries 'Nucleus' (ECO:0000269 PubMed:1374686, 26080397, 29496907), 'Cytoplasm' (ECO:0000269 PubMed:29496907) and 'Membrane' (ECO:0000269 PubMed:1374686), with the note 'Predominantly located in the nucleus but also located partially in the cytoplasm'; tissue specificity is ubiquitous with isoform differences in brain, skeletal muscle and liver [E_q93_khdrbs1_loc1].",
  "AND_NONE_OF_THE_THREE_NUCLEAR_CITATIONS_IS_A_LOCALISATION_STUDY_WHILE_THE_ONE_THAT_IS_GOES_UNCITED": "This is the cleanest rule-91 instance in the tranche and it has the same shape as the MEN1 case the standing brief uses as its worked example. (1) PubMed:1374686 is the 1992 cloning of GAP-associated p62 - sequence similarity to a putative hnRNP protein, nucleic-acid binding, arginine dimethylation, SH2-dependent GAP binding - and its abstract describes NO localisation experiment [E_q93_khdrbs1_loc4]. (2) PubMed:26080397 is a SMAR1/HDAC6 alternative-splicing paper in which the protein whose compartment is measured is SMAR1, enriched in nuclear splicing speckles and moved to the cytoplasm by ERK phosphorylation, not Sam68 [E_q93_khdrbs1_loc5]. (3) PubMed:29496907 is a phosphotyrosine-immunoaffinity phosphoproteomics screen for SRMS kinase substrates - 1,258 phosphopeptides over 663 proteins, WITH NO MICROSCOPY AT ALL, and it is cited for BOTH the nucleus and the cytoplasm. MEANWHILE THE FOUNDING SUBNUCLEAR PAPER - PubMed:10473643, titled 'A role for the GSG domain in LOCALIZING Sam68 to novel nuclear structures in cancer cell lines' - IS NOT CITED ON THE RECORD AT ALL [E_q93_khdrbs1_loc2].",
  "how_shown": "the record's own citations are a 1992 cloning paper, a splicing-regulation paper about another protein's compartment, and a phosphoproteomics screen. The real evidence is immunofluorescence plus GFP fusion plus electron microscopy in the uncited 1999 paper, and proteomics plus co-localisation in a 2009 follow-up",
  "systems": "HeLa and other transformed human lines for the SNB work; the 1992 work is recombinant protein from insect Sf9 cells. No leukaemic cell and no KMT2A-rearranged cell",
  "node": "localization-nuclear-matrix-mitotic-scaffold-kmt2a"
}
cell type
{
  "expressed_in": "UniProt Q07666: 'Ubiquitously expressed in all tissue examined', with isoform 1 lower in brain, skeletal muscle and liver and isoform 3 intensified in skeletal muscle and liver.",
  "measured_in": "HeLa and other TRANSFORMED human lines for the SNB work [E_q93_khdrbs1_loc2][E_q93_khdrbs1_loc3]; insect Sf9-expressed recombinant protein for the 1992 characterisation; MCF-7 breast cancer cells for the SMAR1/HDAC6 axis.",
  "in_this_disease": "This entry's existing E1 is the only study placing KHDRBS1 on this fusion - MLL-AF4 translation inhibited by ribosomal stalling at AU-rich regulatory sites recognised by KHDRBS-family proteins, with synonymous mutations that disrupt KHDRBS association restoring translation and producing leukaemic transformation. THAT IS A TRANSLATIONAL-CONTROL RESULT AND IT IMPLIES A CYTOPLASMIC SITE OF ACTION, on a protein UniProt calls predominantly nuclear. Nobody has measured Sam68's nuclear-to-cytoplasmic partition, or looked for SNBs, in any KMT2A-rearranged cell.",
  "the_compartment_matters_for_this_entrys_own_mechanism": "Ribosomal stalling happens on cytoplasmic ribosomes. If Sam68 is predominantly nuclear and only partially cytoplasmic, then the fusion-dose brake this entry calls its most important finding is exerted by a minority pool of the protein - which makes the partition, not the total, the quantity that sets fusion dose. No paper measures it."
}
cell state
{
  "TRANSFORMATION_IS_THE_DOCUMENTED_STATE_AND_IT_IS_A_POSITIONAL_STATE": "SNBs are predominantly found in TRANSFORMED cells [E_q93_khdrbs1_loc2] and a cell line with low SNB frequency was available to the 2009 study [E_q93_khdrbs1_loc3], so SNB abundance is a variable property of the transformed state rather than a fixed feature of the protein. That is an unusually clean constitutive-versus-induced separation for this beat.",
  "SIGNALLING_IS_THE_SECOND_STATE_AND_IT_RUNS_THROUGH_ACETYLATION": "SMAR1, through HDAC6, maintains Sam68 in a DEACETYLATED state; ERK-1/2 phosphorylation of SMAR1 at T345 and T360 relocates SMAR1 to the CYTOPLASM, preventing its interaction with Sam68 and releasing the inhibitory SMAR1-HDAC6-Sam68 complex, which permits Sam68 acetylation and alternative splicing; loss of heterozygosity at the SMAR1/BANP locus at 16q24.3 in breast cancer cells enhances Sam68 acetylation and CD44 variant exon inclusion [E_q93_khdrbs1_loc5]. So Sam68's ACTIVITY state is set by an upstream protein's COMPARTMENT - an unusual coupling, and the reason UniProt's citation of this paper for Sam68's nucleus is a category slip rather than simple staleness.",
  "and_MITOSIS_is_in_the_name": "Sam68 is Src-Associated in Mitosis, 68 kDa, and the GSG-mutant panel includes a class showing MICROTUBULE association [E_q93_khdrbs1_loc2]. No cell-cycle-resolved localisation of the wild-type protein was located.",
  "bounded": "No KHDRBS1 localisation or cell-state compartment measurement exists in any leukaemic cell, and nothing under a menin inhibitor."
}
localization bounded absence
{
  "date": "2026-09-21",
  "tool": "NCBI E-utilities esearch, db=pubmed",
  "run_by": "Q93",
  "queries": [
    {
      "query": "(\"KHDRBS1\"[tiab] OR \"Sam68\"[tiab] OR \"SAM68\"[tiab])",
      "querytranslation": "\"KHDRBS1\"[Title/Abstract] OR \"Sam68\"[Title/Abstract] OR \"SAM68\"[Title/Abstract]",
      "count": 503,
      "role": "operand control"
    },
    {
      "query": "KHDRBS1[tiab] AND (\"nuclear bodies\"[tiab] OR \"nuclear body\"[tiab] OR \"perinucleolar\"[tiab])",
      "querytranslation": "\"KHDRBS1\"[Title/Abstract] AND (\"nuclear bodies\"[Title/Abstract] OR \"nuclear body\"[Title/Abstract] OR \"perinucleolar\"[Title/Abstract])",
      "count": 0,
      "role": "THE DECISIVE ALIAS MEASUREMENT, half one - the HGNC symbol finds NOTHING"
    },
    {
      "query": "Sam68[tiab] AND (\"nuclear bodies\"[tiab] OR \"nuclear body\"[tiab])",
      "querytranslation": "\"Sam68\"[Title/Abstract] AND (\"nuclear bodies\"[Title/Abstract] OR \"nuclear body\"[Title/Abstract])",
      "count": 14,
      "role": "THE DECISIVE ALIAS MEASUREMENT, half two - 0 against 14"
    },
    {
      "query": "\"Sam68 nuclear bodies\"[tiab]",
      "querytranslation": "\"Sam68 nuclear bodies\"[Title/Abstract]",
      "count": 8,
      "role": "the compartment has its own NAME and eight papers use it as a phrase"
    },
    {
      "query": "\"SNB\"[tiab] AND Sam68[tiab]",
      "querytranslation": "\"SNB\"[Title/Abstract] AND \"Sam68\"[Title/Abstract]",
      "count": 5,
      "role": "acronym control; SNB is also sentinel node biopsy, so it was paired with the gene name rather than used alone"
    },
    {
      "query": "(gene clause) AND (twelve-term subnuclear clause)",
      "count": 24,
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    },
    {
      "query": "(gene clause) AND (nine-term KMT2A/MLL fusion clause)",
      "count": 2,
      "title_check": "PMIDs 17891136 and 16330219; neither is a localisation measurement.",
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    },
    {
      "query": "(gene clause) AND (localisation clause) AND (fusion clause)",
      "count": 0,
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    }
  ],
  "alias_measurement_verdict": "DECISIVE, 0 against 14, and this is the second such case in one tranche after HCFC2 (0 against 2). The HGNC symbol KHDRBS1 retrieves NOTHING about this protein's named subnuclear compartment; the protein name Sam68 retrieves fourteen records and the compartment's own name, 'Sam68 nuclear bodies', retrieves eight. A localisation beat keyed to current symbols would have written 'no subnuclear compartment assigned' for a protein that has an EPONYMOUS ORGANELLE. Tranche 4 measured that this is a per-gene hypothesis, not a rule, and the running score across six genes now stands at three decisive (SKIC8 2:9:43, HCFC2 0:2, KHDRBS1 0:14), two worthless (SGF29/CCDC101 4 versus 44, KAT2A/GCN5L2/hGCN5 0 versus 0 in fusion context) and one decisive-for-provenance-only (CTR9/p150TSP). The pattern in that is not a rule; the cost asymmetry is.",
  "reading": "Titles and abstracts only; supporting figures not searched (brief rule 80).",
  "absence_class": "never-measured"
}
How this could bite us back
  • Targeting a brake is the wrong direction for a drug. If KHDRBS1 restrains the fusion, an inhibitor of it would be expected to make t(4;11) disease worse, and any screen that puts this gene on a target list has read the sign backwards.
  • The therapeutic reading runs the other way - enhance KHDRBS occupancy - and there is no established modality for increasing a sequence-specific RNA-binding protein's engagement with one transcript.
  • Sam68 is pro-proliferative in T-ALL by the only functional study in leukaemia cells. A systemic agent acting on it would have opposite-sign effects in different leukaemias.
  • Every conclusion in this graph of the form 'flat DepMap, therefore dispensable' inherits this entry's problem: the instrument cannot see negative regulators at all.
Still open
  1. Does depleting KHDRBS1 in a human t(4;11) line raise KMT2A::AFF1 protein without changing its transcript, which is the direct prediction and has not been reported?
  2. Are the AU-rich stalling sites present in the endogenous human KMT2A::AFF1 transcript, or only in the retroviral construct whose codon usage the paper had to alter?
  3. If fusion dose is set post-transcriptionally, do patient samples with identical breakpoints differ in fusion protein per unit transcript, and does that track KHDRBS expression?
Every source behind this entry (10)
  1. E1strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    MLL-AF4 protein is post-transcriptionally regulated by RNA-binding proteins including those of the KHDRBS and IGF2BP families: MLL-AF4 translation is inhibited by ribosomal stalling at regulatory sites containing AU-rich sequences recognised by KHDRBSs, and synonymous mutations disrupting KHDRBS association restore proper MLL-AF4 translation and cause leukaemic transformation, with the synonymous mutant inducing leukaemia in vivo.

    What this evidence cannot show

    Abstract read; full text not read. Murine retroviral transduction system. The causal manipulation is a synonymous-mutant construct rather than depletion or over-expression of KHDRBS proteins themselves, so the experiment establishes that the SITES matter more directly than that any one KHDRBS protein does. The abstract names the family, not which member dominates.

    Evidence that argues against this (2)
    • The same paper names the IGF2BP family alongside KHDRBS, and a separate laboratory reports IGF2BP3 binding both reciprocal t(4;11) fusion transcripts and REDUCING KMT2A::AFF1 protein abundance. If two RNA-binding protein families both dampen the fusion's translation, then the widely-cited 'IGF2BP3 amplifies MLL-AF4 leukaemogenesis' result cannot be operating through raising fusion dose, and may be operating despite lowering it. Hanewald T et al. 2026
    • A translational ceiling that must be engineered away to model the disease in mouse raises the possibility that the regulation is a property of the construct and its codon usage rather than of the endogenous human t(4;11) transcript, which is transcribed from its native locus with its native UTRs. Tran TM et al. 2022
  2. E2moderate confidence 3 of 5: One strong study, or several smaller consistent ones.analysis

    DepMap CRISPR (Chronos) gives KHDRBS1 a mean gene effect of -0.127 across 1,208 lines with 4.2% of lines depleted below -0.5, and in the KMT2A-rearranged index arm the difference against 43 other leukaemia lines is POSITIVE: +0.087 in the four B-lymphoid lines and +0.059 in the seven myeloid lines, placing it at the 91.5th percentile of a 458-gene random null. KHDRBS2 (+0.068 / +0.041) and KHDRBS3 (+0.044 / +0.043) behave the same way.

    What this evidence cannot show

    Eleven index lines, four lymphoid. The positive sign is within the null distribution and is not itself a finding; what is reported is the absence of a dependency, in a gene the literature says is a repressor.

    Evidence that argues against this (1)
    • Reading a flat-to-positive Chronos as CONFIRMING the repressor model would be over-reading. Most genes are flat in DepMap, and a null result is consistent with the repressor model, with a redundant family, and with the gene doing nothing in these lines. What the row rules out is a strong requirement, nothing more. Oncofusion knowledge graph (internal analysis) 2026
  3. E3moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    Sam68 silencing in human adult T-cell acute lymphoblastic leukaemia cells reduces proliferation and promotes apoptosis through the AKT/mTOR pathway.

    What this evidence cannot show

    Abstract-level; cell lines, adult T-ALL, and a signalling-pathway readout rather than an RNA-binding mechanism. It is a different lineage and a different disease from the index disease here.

    Evidence that argues against this (1)
    • This is the opposite sign to the MLL-AF4 result: pro-proliferative in T-ALL, restraining in MLL-AF4. Both can be true - the function of an RNA-binding protein is set by which messages it occupies, which differs by lineage and by what the cell transcribes - but it means no general statement about Sam68 in leukaemia is available, and an inhibitor's direction of effect would be disease-specific. Okuda H et al. 2022
  4. E4established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.database

    UniProtKB Q07666 (KHDR1_HUMAN) is human KHDRBS1, 443 amino acids; the accession was resolved by a gene_exact query with the primary gene name read back as KHDRBS1 and the length checked.

    What this evidence cannot show

    The primary-name assertion matters: this project has logged six cases of gene_exact returning a protein that merely lists the queried symbol as a synonym. The query returned exactly one reviewed human entry and its primary gene name equals the query.

    Evidence that argues against this (1)
    • A UniProt header gives an accession, a symbol and a length and says nothing about function in this disease. KHDRBS1 also has two paralogues, KHDRBS2 and KHDRBS3, with the same KH/STAR architecture, so any question about selectivity begins where the accession stops. UniProt Consortium 2026
  5. E_q93_khdrbs1_loc1established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.database

    UniProt Q07666 records Sam68 as predominantly nuclear and partially cytoplasmic, with Nucleus attributed to ECO:0000269 PubMed:1374686, 26080397 and 29496907, Cytoplasm to 29496907 and Membrane to 1374686 - and NONE of those three papers is a Sam68 localisation study, while the paper that established the Sam68 nuclear bodies (PubMed:10473643) is not cited on the record.

    What this evidence cannot show

    A statement about the record. The compartment itself is not in dispute - Sam68 is nuclear and everyone agrees - so no reader is misled about the biology. What is lost is the entire subnuclear layer: a named organelle, its distinctness from coiled bodies, gems and PML bodies, its transformation-dependence, and its component list. All three defects this beat can check for (citation not about the fact, founding paper absent, informative layer missing) are present on one record.

    Evidence that argues against this (1)
    • The strongest defence of the record is that the three citations are not random: each one does contain a nucleus-relevant observation somewhere in its figures - a 1992 paper reporting DNA and mRNA binding by a dimethylated hnRNP-like protein, a splicing paper with Sam68 in a nuclear complex, a phosphoproteomics study that necessarily fractionated cells. So a curator reading widely could justify all three. The objection is that this is exactly what brief rule 91 says an evidence code does NOT establish: that the paper is about your fact, is the founding observation, or is the best available. Here the best available paper has the word LOCALIZING in its title and is absent. Chen T et al. 1999
  6. E_q93_khdrbs1_loc2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    In TRANSFORMED HUMAN CELL LINES, Sam68 concentrates into novel nuclear structures - Sam68 nuclear bodies (SNBs) - that are predominantly found in transformed cells and are DISTINCT from coiled bodies, gems and promyelocytic nuclear bodies; electron microscopy shows SNBs are discrete structures enriched in phosphorus and nitrogen indicating nucleic acids; GFP-Sam68 reproduces the endogenous pattern in HeLa, diffusely nuclear with two to five SNBs; SLM-1 and SLM-2 co-localise with endogenous Sam68 in SNBs; and GSG-domain missense mutations yield six separable cellular patterns including exclusive SNB localisation and association with microtubules.

    A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. · Chen T, Boisvert FM, Bazett-Jones DP, Richard S · Mol Biol Cell 1999
    What this evidence cannot show

    HeLa and other transformed human lines - no primary cell, nothing haematopoietic, nothing fusion-bearing (brief rule 73, and the claim names the system first). The mutant-pattern panel is overexpression of GSG variants, so the six classes describe what mutant constructs do rather than physiological states. 'Predominantly found in transformed cells' is a comparative claim across lines whose quantification the abstract does not give. Bounded by the abstract.

    Evidence that argues against this (1)
    • The body's own physiological status is open, and this graph has a standing reason to be careful about it: localization-condensate-evidence-standards records that the commonest assays cannot distinguish phase separation from binding to spatially clustered sites, and that low-complexity-domain interactions at physiological expression form dynamic hubs WITHOUT detectable phase separation. Two to five discrete structures per nucleus, seen most clearly in transformed lines, enriched in nucleic acid, is a description consistent with either model - and the 2009 follow-up strengthens the caution by showing the Sam68-hnRNP L interaction occurs in a cell line with LOW SNB frequency, i.e. outside the bodies. So SNBs are a real, named, EM-visible compartment whose functional necessity is not established. Rajan P et al. 2009
  7. E_q93_khdrbs1_loc3moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    SLM/Sam68 nuclear bodies are described as subnuclear organelles containing splicing regulators, signalling components and nucleic acids; proteomics of nuclear Sam68 identified hnRNP L as a novel interacting partner that spatially co-localises with Sam68 as a component of SNBs while also present in the general nucleoplasm, and this SNB localisation is specific to hnRNP L and not shared by the closely related hnRNP LL; the Sam68-hnRNP L interaction was also observed in a cell line exhibiting a LOW FREQUENCY of SNBs, indicating the association also takes place outside them.

    Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies. · Rajan P, Dalgliesh C, Bourgeois CF, Heiner M, Emami K, Clark EL, Bindereif A, Stevenin J, Robson CN, Leung HY, Elliott DJ · BMC Cell Biol 2009
    What this evidence cannot show

    Human cell lines, not haematopoietic and not fusion-bearing (brief rule 73). The compartment assignment rests on co-localisation microscopy alongside interaction proteomics, so component membership is inferred from spatial overlap at light-microscope resolution rather than from purification of the body. Bounded by the abstract.

    Evidence that argues against this (1)
    • The low-SNB-frequency observation is the part that argues against treating SNBs as Sam68's functional address, and it is the authors' own reasoning rather than an outside objection. If the interaction that the bodies are supposed to house happens in a cell line that barely has them, then SNBs concentrate a chemistry that does not require them - which is the same conclusion this graph reached for the SEC and for PRC1/CBX2 condensates, and the reason localization-condensate-evidence-standards insists on saying which model the evidence can support. For this entry the practical consequence is that a Sam68 experiment in a KMT2A-rearranged blast should count SNBs and measure partition, not assume the bodies are where the action is. Chen T et al. 1999
  8. E_q93_khdrbs1_loc4strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    PubMed:1374686, which UniProt cites for BOTH Sam68's nuclear and membrane localisations, is the 1992 molecular cloning of the GAP-associated tyrosine phosphoprotein p62, reporting sequence similarity to a putative hnRNP protein, DNA and mRNA binding by recombinant protein purified from insect Sf9 cells, arginine dimethylation, and phosphotyrosine-dependent binding to p120-GAP SH2 regions - and its abstract describes no localisation experiment.

    Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. · Wong G, Müller O, Clark R, Conroy L, Moran MF, Polakis P, McCormick F · Cell 1992
    What this evidence cannot show

    Bounded by the abstract; a subcellular fractionation or immunofluorescence panel may exist in the paper. The membrane attribution is the more puzzling of the two, since a GAP-associated phosphoprotein would plausibly be recovered at the membrane, but nothing in the abstract reports that measurement. Insect-cell recombinant protein is not a localisation system at all.

    Evidence that argues against this (1)
    • The historical reading defends UniProt and is worth recording, because it explains a pattern this beat keeps finding. In 1992 this protein was a RAS-GAP-associated phosphoprotein, not a splicing factor; the nuclear-body work came seven years later from a different community. A curator building the record chronologically anchors the compartment to the oldest paper that touched it, and the record then ages in place. That is the mechanism behind the MEN1 case in brief rule 91 and behind this one, and it predicts where to look next: any protein renamed between its discovery and its current function is a candidate for a compartment annotation stranded in the old literature. Chen T et al. 1999
  9. E_q93_khdrbs1_loc5strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    SMAR1, a nuclear-matrix-associated protein enriched in nuclear splicing SPECKLES, negatively regulates alternative splicing through HDAC6-mediated deacetylation of Sam68; ERK-1/2 phosphorylation of SMAR1 at threonines 345 and 360 relocalises SMAR1 to the CYTOPLASM and prevents its interaction with Sam68, releasing the inhibitory SMAR1-HDAC6-Sam68 complex and permitting Sam68 acetylation and alternative splicing; loss of heterozygosity at the SMAR1/BANP locus at chromosome 16q24.3 in breast cancer cells enhances Sam68 acetylation and CD44 variant exon inclusion.

    Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68. · Nakka KK, Chaudhary N, Joshi S, Bhat J, Singh K, Chatterjee S, Malhotra R, De A, Santra MK, Dilworth FJ, Chattopadhyay S · Proc Natl Acad Sci U S A 2015
    What this evidence cannot show

    MCF-7 and breast cancer cells plus mouse tail-vein injection - not haematopoietic, not fusion-bearing (brief rule 73, and the claim names the system). Cited by UniProt for SAM68's nucleus, but the protein whose compartment this paper measures is SMAR1: the speckle enrichment and the ERK-driven cytoplasmic relocation are SMAR1's. Bounded by the abstract.

    Evidence that argues against this (1)
    • This is a rule-91 case where the mis-pointed citation nevertheless carries something the beat wanted, which is the direction the standing brief asks to be reported. UniProt cites it for the wrong protein's compartment - and the paper supplies the only mechanism in this gene's literature by which an UPSTREAM protein's relocalisation switches Sam68's post-translational state, plus a named subnuclear neighbourhood (nuclear splicing speckles) in which the regulator sits. So the citation is wrong for the field it is attached to and useful for the entry as a whole, which is a distinction a coverage metric cannot see and a reader can. Rajan P et al. 2009
  10. E_q93_khdrbs1_loc6strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.database

    Bounded 2026-09-21: KHDRBS1[tiab] AND ("nuclear bodies"[tiab] OR "nuclear body"[tiab] OR perinucleolar[tiab]) returns ZERO records while Sam68[tiab] AND the nuclear-bodies clause returns 14 and the exact phrase "Sam68 nuclear bodies"[tiab] returns 8; the gene clause over all three spellings returns 503; against a nine-term KMT2A/MLL fusion clause it returns 2, neither a localisation measurement; and against a localisation clause AND the fusion clause it returns 0.

    What this evidence cannot show

    Titles and abstracts only; supporting figures not searched (brief rule 80). The SNB acronym was deliberately not searched alone, because SNB is also sentinel node biopsy; it was paired with the gene name, returning 5. The 24-record count against the full twelve-term subnuclear clause was not title-screened exhaustively and is reported only as context.

    Evidence that argues against this (1)
    • The 0-versus-14 split is the most consequential alias result this project has measured, and the reason is not the ratio but WHAT sits on the far side of it: an eponymous organelle. A beat searching only HGNC symbols would have recorded 'no subnuclear compartment assigned' for the one protein in this tranche that has a nuclear body named after it, and that false absence would have read as perfectly well-bounded. Against the temptation to promote alias search to a rule, note that the same tranche found it worthless on KAT2A - so the honest generalisation is only the cost asymmetry, and the specific one is brief rule 69's: when a protein is better known by a name that is not its symbol, the symbol is the wrong instrument. Chen T et al. 1999
Connected to